2. ASIA 2 X 27
2. ASIA 2 X 27 Asia vulnerable to U.S.-style accounting fiascos despite reforms
3. Spore 2 X 20 No quick relief for fussy Singaporeans
4. Drug 3 X 20 Bristol-Myers, Merck cases mark struggles of drug industry
2. ASIA 2 X 27 Asia vulnerable to U.S.-style accounting fiascos despite reforms
3. Spore 2 X 20 No quick relief for fussy Singaporeans
4. Drug 3 X 20 Bristol-Myers, Merck cases mark struggles of drug industry